Quintiles Transitional Holdings (NYSE: Q) is one of 198 publicly-traded companies in the “Biotechnology & Medical Research” industry, but how does it contrast to its rivals? We will compare Quintiles Transitional Holdings to similar companies based on the strength of its analyst recommendations, valuation, profitability, risk, earnings, dividends and institutional ownership.
Earnings and Valuation
This table compares Quintiles Transitional Holdings and its rivals top-line revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Quintiles Transitional Holdings||$6.97 billion||$1.51 billion||139.48|
|Quintiles Transitional Holdings Competitors||$207.78 million||-$2.31 million||0.70|
Quintiles Transitional Holdings has higher revenue and earnings than its rivals. Quintiles Transitional Holdings is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Risk & Volatility
Quintiles Transitional Holdings has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, Quintiles Transitional Holdings’ rivals have a beta of 1.63, suggesting that their average stock price is 63% more volatile than the S&P 500.
Institutional and Insider Ownership
93.2% of Quintiles Transitional Holdings shares are held by institutional investors. Comparatively, 46.7% of shares of all “Biotechnology & Medical Research” companies are held by institutional investors. 6.4% of Quintiles Transitional Holdings shares are held by company insiders. Comparatively, 13.8% of shares of all “Biotechnology & Medical Research” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
This is a breakdown of recent ratings and price targets for Quintiles Transitional Holdings and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Quintiles Transitional Holdings||0||10||9||0||2.47|
|Quintiles Transitional Holdings Competitors||476||2258||6160||119||2.66|
Quintiles Transitional Holdings currently has a consensus target price of $93.64, suggesting a potential downside of 8.03%. As a group, “Biotechnology & Medical Research” companies have a potential upside of 14.14%. Given Quintiles Transitional Holdings’ rivals stronger consensus rating and higher probable upside, analysts clearly believe Quintiles Transitional Holdings has less favorable growth aspects than its rivals.
This table compares Quintiles Transitional Holdings and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Quintiles Transitional Holdings||0.82%||14.23%||5.07%|
|Quintiles Transitional Holdings Competitors||-3,956.95%||-118.19%||-43.57%|
Quintiles Transitional Holdings beats its rivals on 7 of the 13 factors compared.
Quintiles Transitional Holdings Company Profile
Quintiles IMS Holdings, Inc., formerly Quintiles Transnational Holdings Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.